Board of Directors

Ms. Maria Gobbi (Non-Executive Chairperson)

Ms. Maria Gobbi holds a degree in 'Chemical Engineering' from the University of Politecnico, Milan, Italy. She has experience of three decades in pharmaceutical industry at international level.

Ms. Gobbi is Non-Executive Chairperson of the Company and immediate past Managing Director of Fresenius Kabi Oncology Limited. She is also the Executive Vice President, BU-API. Prior to her association with Fresenius Kabi, she was the General Manager of Antibioticos Spain and VP of Sales and Marketing of Alpharma Aps, a USA based company located in Scandinavian Countries and manufacturing mainly Antibiotics, both APIs and Finished Products.

In her illustrious professional career, she has handled many critical assignments related to accessing new markets, diversifying customer's portfolio, optimizing manufacturing set-up, driving the companies toward FDA approved status etc. She has been also playing a key role in the revival plan for Kalyani facility of the Company.

Dr. Michael Schönhofen (Non-Executive Director)

Dr. Michael Schönhofen holds a Doctorate degree from Gesellschaft für Schwerionenforschung, Darmstadt, Germany and College of Advanced Technology, Darmstadt. Dr. Schönhofen has been associated with the Fresenius group since 1991 in various functions and responsibilities. He is currently holding the position of President, Pharmaceuticals and Devices Division and is also a Member of the Management Board of Fresenius Kabi AG, Germany.

Steffen Roser (Non - Executive Director)

Mr. Steffen Roser obtained his Master's Degree in Business Administration from the Frankfurt University, Germany in 1988.

In year 1989, he started his professional career as a Controller with Procter & Gamble. He joined Fresenius Group in year 1994 as a Controller Corporate and since then has handled many critical assignments within the Fresenius group at different positions. Currently he is acting as the CFO of Pharmaceutical and Devices Division at Fresenius Kabi, Germany.

Dr. Uday Chandrashekhar Shetty (Non-Executive Independent Director)

Dr. Uday Chandrashekhar Shetty holds a Ph.D (Tech) from the Mumbai University. He is a Pharmaceutical professional with over 30 years of experience in Quality Management, Product Development, Technology Transfers and Manufacturing Operations.

He has vast experience in EHS, Engineering, Purchase, Finance and Marketing/ Sales for CRO’s. Previously, he has served as the co-founder Director of a Contract Research Organization. He has also gained unparallel experience while working with leading pharmaceutical companies like Janssen, Burroughs Wellcome and American Cyanamid.

Presently, Dr. Shetty serves as the Director of “GMP Education” a non-profit organization which imparts free online Pharmaceutical Education. Additionally, he also serves as the Chairman of the International Society of Pharmaceutical Engineering, India affiliate and as a member of the Technical Committee of Indian Drug Manufacturer’s Association.

Mr. Arvind Kumar Sharma (Managing Director)

Mr. Arvind Kumar Sharma has over 30 years of experience in the manufacturing of Bulk Pharmaceutical Chemicals (APIs) & Biopharmaceuticals. Mr. Sharma completed his B. Tech in Biochemical Engineering from H.B.T.I., Kanpur and M. Tech in Biotechnology from Jadavpur University, Calcutta. He has been associated with the Company since June, 2013 and has been efficiently leading the Kalyani plant operations since then. He has also been leading operations of the Baddi plant since July, 2017.

During his rich experience, he has worked in leadership positions with specialist pharmaceutical companies such as Arch Pharmalabs Limited, Vitalife Laboratories, Concord Biotech Limited and KDL Biotech Limited. His area of expertise spans across manufacturing excellence, operations improvement, planning and systems development and workflow planning.

Mr. Nikhil Kulshreshtha (Director & Secretary)

Mr. Nikhil Kulshreshtha is a member of the Institute of Company Secretaries of India (ICSI). He has also attended management and leadership programs from national and international management institutions like IIM (Ahmadabad), NUS, Singapore etc. Mr. Kulshreshtha has overall 29 years of professional experience and has been associated with the Company since the year 2007. During this period, he has worked in different capacities with large Indian conglomerates like Bharti Airtel, HCL and DLF, handling secretarial, legal, commercial, accounts and administrative functions. In his professional career, he has acquired extensive hands on experience in handling Mergers & Acquisition, Legal Due Diligence, Integration, IPO's & ESOP formulation and Statutory Compliances etc.

Mr. Zankar Himatlal Pandya (Chief Financial Officer)

Mr. Zankar Himatlal Pandya holds a Degree in Bachelor of Business Administration (BBA) from Maharaja Sayajirao University (Baroda, India) and has also completed Master of Business Administration (MBA) from University of Wollongong (Wollongong), Australia.

Mr. Zankar Himatlal Pandya is also a CPA ("Certified Practising Accountant") professional from Australia, having a diverse work experience of over 15 years locally in India and at an international level. He has gained this experience in various roles involving functions analysis related to Sales and Marketing, Supply Chain activities, Financial Consolidation, Financial reporting, Controlling of Overheads, manufacturing activities and Australia and New Zealand Taxation and Financial Management.

He commenced his Career as ‘Commissions Analyst’ with MLC, a National Group Company, North Sydney in 2004 and subsequently moved on to work with Commander Communications Ltd., Australia. This was followed by an enriching stint with Reckitt Benckiser, Australia as Commercial Analyst & Reckitt Benckiser India as Finance Manager.

He joined Fresenius Kabi Oncology Ltd. in June, 2015 as Deputy General Manager- Finance & Accounts looking after Controlling, Finance & Accounts and Taxation activities at PU-Baddi. In 2017, he was promoted to General Manager-Controlling taking the overall responsibilities of consolidating Controlling function for FKOL whilst retaining the responsibilities for PU-Baddi.

Before appointment as CFO, he was holding the position of General Manager-Controlling and the responsibilities of Deputy CFO.